Dr Reddy's Laboratories Q3 EPS $0.99 Beats $0.79 Estimate, Sales $866.64M Beat $825.86M Estimate

Dr. Reddy's Laboratories Ltd. Sponsored ADR +0.31%

Dr. Reddy's Laboratories Ltd. Sponsored ADR

RDY

68.92

+0.31%

Dr Reddy's Laboratories (NYSE: RDY) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.79 by 25.7 percent. This is a 9.12 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $866.64 million which beat the analyst consensus estimate of $825.86 million by 4.94 percent. This is a 5.10 percent increase over sales of $824.61 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via